Single nucleotide variants (SNVs) define senescence-accelerated SAMP8 mice, a model of a geriatric condition

Journal of Alzheimer's Disease

Volumn 36, Issue 2, 2013, Pages 349-363

  Delerue, Fabien ^a   Sjollema, Geoff ^b   Whittle, Belinda ^b   Krüger, Sarah ^a   Andrews, Dan ^b   Götz, Jürgen ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Biology and Environment   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Alzheimer's disease; exome sequencing; mouse; senescence; sequence nucleotide variants

Indexed keywords

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DYSFUNCTION; CONTROLLED STUDY; EXOME; GENE MUTATION; GENE SEQUENCE; GENOTYPE; IMMUNE DYSREGULATION; LIFESPAN; MOUSE; NERVE DEGENERATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SENESCENCE; SENESCENCE ACCELERATED MOUSE;

EID: 84879659939     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-130089     Document Type: Article

References (56)

1. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (2011) Alzheimer's disease. Lancet 377, 1019-1031
2. Gotz J, Ittner LM (2008) Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev Neurosci 9, 532-544 (Pubitemid 351873467)
3. Del Valle J, Bayod S, Camins A, Beas-Zarate C, Velazquez-Zamora DA, Gonzalez-Burgos I, Pallas M (2012) Dendritic spine abnormalities in hippocampal CA1 pyramidal neurons underlying memory deficits in the SAMP8 mouse model of Alzheimer's disease. J Alzheimers Dis 32, 233-240
4. Pallas M, Camins A, Smith MA, Perry G, Lee HG, Casadesus G (2008) From aging to Alzheimer's disease: Unveiling "the switch" with the senescence-Accelerated mouse model (SAMP8). J Alzheimers Dis 15, 615-624
5. Takeda T (1999) Senescence-Accelerated mouse (SAM): A biogerontological resource in aging research. Neurobiol Aging 20, 105-110 (Pubitemid 29488720)
6. Shimada A, Hasegawa-Ishii S (2011) Senescence-Accelerated mice (SAMs) as a model for brain aging and immunosenescence. Aging Dis 2, 414-435
7. Flood JF, Morley JE (1998) Learning and memory in the SAMP8 mouse. Neurosci Biobehav Rev 22, 1-20 (Pubitemid 28082281)
8. Cheng H, Yu J, Jiang Z, Zhang X, Liu C, Peng Y, Chen F, Qu Y, Jia Y, Tian Q, Xiao C, Chu Q, Nie K, Kan B, Hu X, Han J (2008) Acupuncture improves cognitive deficits and regulates the brain cell proliferation ofSAMP8mice. Neurosci Lett 432, 111-116
9. Flood JF, Farr SA, Uezu K, Morley JE (1998) Age-related changes in septal serotonergic,GABAergic and glutamatergic facilitation of retention in SAMP8 mice. Mech Ageing Dev 105, 173-188 (Pubitemid 28539188)
10. Ikegami S, Shumiya S, Kawamura H (1992) Age-related changes in radial-Arm maze learning and basal forebrain cholinergic systems in senescence accelerated mice (SAM). Behav Brain Res 51, 15-22
11. Chen GH,Wang YJ,Wang XM, Zhou JN (2004) Accelerated senescence prone mouse-8 shows early onset of deficits in spatial learning and memory in the radial six-Arm water maze. Physiol Behav 82, 883-890
12. McGaugh JL (1966) Time-Dependent processes in memory storage. Science 153, 1351-1358
13. Senechal Y, Kelly PH, Dev KK (2008) Amyloid precursor protein knockout mice showage-Dependent deficits in passive avoidance learning. Behav Brain Res 186, 126-132 (Pubitemid 350100902)
14. MiyamotoM(1994) [Experimental techniques for developing new drugs acting on dementia (8)-Characteristics of behavioral disorders in senescence- Accelerated mouse (SAMP8): Possible animal model for dementia]. Nihon Shinkei Seishin Yakurigaku Zasshi 14, 323-335 (Pubitemid 24370704)
15. Miyamoto M (1997) Characteristics of age-related behavioral changes in senescence-Accelerated mouse SAMP8 and SAMP10. Exp Gerontol 32, 139-148 (Pubitemid 27131713)
16. Schmitt K, Grimm A, Kazmierczak A, Strosznajder JB, Gotz J, Eckert A (2012) Insights into mitochondrial dysfunction: Aging, amyloid-beta, and tau-A deleterious trio. Antioxid Redox Signal 16, 1456-1466
17. Kurokawa T, Asada S, Nishitani S, Hazeki O (2001) Agerelated changes in manganese superoxide dismutase activity in the cerebral cortex of senescence-Accelerated prone and resistant mouse. Neurosci Lett 298, 135-138 (Pubitemid 32037073)
18. Sato E, Oda N, Ozaki N, Hashimoto S, Kurokawa T, Ishibashi S (1996) Early and transient increase in oxidative stress in the cerebral cortex of senescence-Accelerated mouse. Mech Ageing Dev 86, 105-114 (Pubitemid 26069348)
19. Okatani Y,Wakatsuki A, Reiter RJ, Miyahara Y (2002) Melatonin reduces oxidative damage of neural lipids and proteins in senescence-Accelerated mouse. Neurobiol Aging 23, 639-644 (Pubitemid 34493894)
20. Yasui F, Ishibashi M, Matsugo S, Kojo S, Oomura Y, Sasaki K (2003) Brain lipid hydroperoxide level increases in senescence-Accelerated mice at an early age. Neurosci Lett 350, 66-68 (Pubitemid 37289255)
21. Kurokawa T, Sato E, Inoue A, Ishibashi S (1996) Evidence that glucose metabolism is decreased in the cerebrum of aged female senescence-Accelerated mouse ; possible involvement of a low hexokinase activity. Neurosci Lett 214, 45-48 (Pubitemid 26273985)
22. Kitamura Y, Zhao XH, Ohnuki T, Nomura Y (1989) Ligand-binding characteristics of [3H]QNB, [3H]prazosin, [3H]rauwolscine, [3H]TCP and [3H]nitrendipine to cerebral cortical and hippocampal membranes of senescence accelerated mouse. Neurosci Lett 106, 334-338 (Pubitemid 20008870)
23. Canudas AM, Gutierrez-Cuesta J, Rodriguez MI, Acuna-Castroviejo D, Sureda FX, Camins A, Pallas M (2005) Hyperphosphorylation of microtubule-Associated protein tau in senescence-Accelerated mouse (SAM). Mech Ageing Dev 126, 1300-1304 (Pubitemid 41572247)
24. Gotz J, Gladbach A, Pennanen L, Van Eersel J, Schild A, David D, Ittner LM (2010) Animal models reveal role for tau phosphorylation in human disease. Biochim Biophys Acta 1802, 860-871
25. Gutierrez-Cuesta J, Sureda FX, Romeu M, Canudas AM, Caballero B, Coto-Montes A, Camins A, Pallas M (2007) Chronic administration of melatonin reduces cerebral injury biomarkers in SAMP8. J Pineal Res 42, 394-402 (Pubitemid 46581664)
26. Takemura M, Nakamura S, Akiguchi I, Ueno M, Oka N, Ishikawa S, Shimada A, Kimura J, Takeda T (1993) Beta/A4 proteinlike immunoreactive granular structures in the brain of senescence-Accelerated mouse. Am J Pathol 142, 1887-1897 (Pubitemid 24057083)
27. Fukunari A, Kato A, Sakai Y, Yoshimoto T, Ishiura S, Suzuki K, Nakajima T (1994) Colocalization of prolyl endopeptidase and amyloid beta-peptide in brains of senescence-Accelerated mouse. Neurosci Lett 176, 201-204
28. Kumar VB, Farr SA, Flood JF, Kamlesh V, Franko M, BanksWA, Morley JE (2000) Site-Directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice. Peptides 21, 1769-1775 (Pubitemid 32058851)
29. Morley JE, Kumar VB, Bernardo AE, Farr SA, Uezu K, Tumosa N, Flood JF (2000) Beta-Amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides 21, 1761-1767 (Pubitemid 32058850)
30. Nomura Y, Yamanaka Y, Kitamura Y, Arima T, Ohnuki T, Oomura Y, Sasaki K, Nagashima K, Ihara Y (1996) Senescence-Accelerated mouse. Neurochemical studies on aging. Ann N Y Acad Sci 786, 410-418
31. Sureda FX, Gutierrez-Cuesta J, Romeu M, Mulero M, Canudas AM, Camins A, Mallol J, Pallas M (2006) Changes in oxidative stress parameters and neurodegeneration markers in the brain of the senescence-Accelerated mice SAMP-8. Exp Gerontol 41, 360-367
32. Andrews TD, Whittle B, Field MA, Balakishnan B, Zhang Y, Shao Y, Cho V, Kirk M, Singh M, Xia Y, Hager J, Winslade S, Sjollema G, Beutler B, Enders A, Goodnow CC (2012) Massively parallel sequencing of the mouse exome to accurately identify rare, induced mutations: An immediate source for thousands of new mouse models. Open Biol 2, 120061
33. Lim YA, Giese M, Shepherd C, Halliday G, Kobayashi M, Takamatsu K, Staufenbiel M, Eckert A, Gotz J (2012) Role of hippocalcin in mediating Abeta toxicity. Biochim Biophys Acta 1822, 1247-1257
34. Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760
35. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R (2009) The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079
36. Wang K, Li M, Hakonarson H (2010) ANNOVAR: Functional annotation of genetic variants from high-Throughput sequencing data. Nucleic Acids Res 38, e164
37. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7, 248-249
38. Morley JE, Armbrecht HJ, Farr SA, Kumar VB (2012) The senescence accelerated mouse (SAMP8) as a model for oxidative stress and Alzheimer's disease. Biochim Biophys Acta 1822, 650-656
39. Swistowski A, Zhang Q, Orcholski ME, Crippen D, Vitelli C, Kurakin A, Bredesen DE (2009) Novel mediators of amyloid precursor protein signaling. J Neurosci 29, 15703-15712
40. Schonrock N, Matamales M, Ittner LM, Gotz J (2011) MicroRNA networks surrounding APP and amyloid-beta metabolism -Implications for Alzheimer's disease. Exp Neurol 235, 447-454
41. Glasmacher E, Hoefig KP, Vogel KU, Rath N, Du L, Wolf C, Kremmer E,Wang X, Heissmeyer V (2010) Roquin binds inducible costimulator mRNA and effectors of mRNA decay to induce microRNA-independent post-Transcriptional repression. Nat Immunol 11, 725-733
42. Ko JL, Liu HC, Loh HH (2003) Role of an AP-2-Like element in transcriptional regulation of mouse mu-opioid receptor gene. Brain Res Mol Brain Res 112, 153-162 (Pubitemid 36369257)
43. Ke Y, Dramiga J, Schutz U, Kril JJ, Ittner LM, Schroder H, Gotz J (2012) Tau-mediated nuclear depletion and cytoplasmic accumulation of SFPQ in Alzheimer's and Pick's disease. PLoS One 7, e35678
44. Johne C, Matenia D, Li XY, Timm T, Balusamy K, Mandelkow EM (2008) Spred1 and TESK1-Two new interaction partners of the kinase MARKK/TAO1 that link the microtubule and actin cytoskeleton. Mol Biol Cell 19, 1391-1403 (Pubitemid 351805094)
45. Meyer HA, Hartmann E (1997) The yeast SPC22/23 homolog Spc3p is essential for signal peptidase activity. J Biol Chem 272, 13159-13164 (Pubitemid 27216741)
46. Sun Y, Almomani R, Breedveld GJ, Santen GW, Aten E, Lefeber DJ, Hoff JI, Brusse E, Verheijen FW, Verdijk RM, Kriek M, Oostra B, Breuning MH, Losekoot M, den Dunnen JT, Van de Warrenburg BP, Maat-Kievit AJ (2013) Autosomal recessive spinocerebellar ataxia 7 (SCAR7) is caused by variants in TPP1, the gene involved in classic late-infantile neuronal ceroid lipofuscinosis 2 disease (CLN2 Disease). Hum Mutat 34, 706-713
47. DelatyckiMB,CorbenLA(2012) Clinical features of Friedreich ataxia. J Child Neurol 27, 1133-1137
48. Taguchi A,WartschowLM, WhiteMF(2007) Brain IRS2 signaling coordinates life span and nutrient homeostasis. Science 317, 369-372 (Pubitemid 47106376)
49. Choudhury AI, Heffron H, Smith MA, Al-Qassab H, Xu AW, Selman C, Simmgen M, Clements M, Claret M, Maccoll G, Bedford DC, Hisadome K, Diakonov I, Moosajee V, Bell JD, Speakman JR, Batterham RL, Barsh GS, Ashford ML, Withers DJ (2005) The role of insulin receptor substrate 2 in hypothalamic and beta cell function. J Clin Invest 115, 940-950 (Pubitemid 40489398)
50. Sadagurski M, Cheng Z, Rozzo A, Palazzolo I, Kelley GR, Dong X, Krainc D, White MF (2011) IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease. J Clin Invest 121, 4070-4081
51. Martin ED, Sanchez-Perez A, Trejo JL, Martin-Aldana JA, Cano Jaimez M, Pons S, Acosta Umanzor C, Menes L, WhiteMF, Burks DJ (2012) IRS-2 Deficiency impairsNMDA receptor-Dependent long-Term potentiation. Cereb Cortex 22, 1717-1727
52. Irvine EE, Drinkwater L, Radwanska K, Al-Qassab H, Smith MA, O'Brien M, Kielar C, Choudhury AI, Krauss S, Cooper JD,Withers DJ, Giese KP (2011) Insulin receptor substrate 2 is a negative regulator of memory formation. Learn Mem 18, 375-383
53. Pennanen L, Wolfer DP, Nitsch RM, Gotz J (2006) Impaired spatial reference memory and increased exploratory behavior in P301L tau transgenic mice. Genes Brain Behav 5, 369-379 (Pubitemid 44000922)
54. Liu X, Dobbie M, Tunningley R, Whittle B, Zhang Y, Ittner LM, Gotz J (2011) ENU mutagenesis screen to establish motor phenotypes in wild-Type mice and modifiers of a preexisting motor phenotype in tau mutant mice. J Biomed Biotechno 2011, 130947
55. Ittner LM,Ke YD, Gotz J (2009) PhosphorylatedTau Interacts with c-Jun N-Terminal Kinase-interacting Protein 1 (JIP1) in Alzheimer Disease. J Biol Chem 284, 20909-20916
56. Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, Van Eersel J, Wolfing H, Chieng BC, Christie MJ, Napier IA, Eckert A, Staufenbiel M, Hardeman E, Gotz J (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 142, 387-397